![Marie-Noëlle Ip](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
Marie-Noëlle Ip worked as a Program Director at the Council of Canadian Academies, an Operations Director at Verlyx Pharma, Inc., and a Principal at BCE, Inc. from 1989 to 2003.
Former positions of Marie-Noëlle Ip
Companies | Position | End |
---|---|---|
BCE INC. | Corporate Officer/Principal | 2002-12-31 |
Council of Canadian Academies | Corporate Officer/Principal | - |
Verlyx Pharma, Inc.
![]() Verlyx Pharma, Inc. Pharmaceuticals: MajorHealth Technology Verlyx Pharma, Inc. develops cancer treatments. It is a pharmaceutical company involved in the development of liver-targeting therapeutic agents for the treatment of liver diseases. The firm’s product VLX103, is a proprietary form of pentamidine that combines hepatoselective and hepatoprotective properties. The company was founded in 1999 by Terry Chow and David Griller and is headquartered in Montréal, Canada. | Chief Operating Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
BCE INC. | Communications |
Private companies | 2 |
---|---|
Verlyx Pharma, Inc.
![]() Verlyx Pharma, Inc. Pharmaceuticals: MajorHealth Technology Verlyx Pharma, Inc. develops cancer treatments. It is a pharmaceutical company involved in the development of liver-targeting therapeutic agents for the treatment of liver diseases. The firm’s product VLX103, is a proprietary form of pentamidine that combines hepatoselective and hepatoprotective properties. The company was founded in 1999 by Terry Chow and David Griller and is headquartered in Montréal, Canada. | Health Technology |
Council of Canadian Academies |
- Stock Market
- Insiders
- Marie-Noëlle Ip